EverSource Wealth Advisors’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.4K | Buy |
449
+197
| +78% | +$43.2K | ﹤0.01% | 1215 |
|
|
2025
Q1 | $56.3K | Sell |
252
-383
| -60% | -$85.6K | ﹤0.01% | 1180 |
|
|
2024
Q4 | $208K | Buy |
635
+537
| +548% | +$176K | 0.01% | 640 |
|
|
2024
Q3 | $29.4K | Sell |
98
-145
| -60% | -$43.5K | ﹤0.01% | 1292 |
|
|
2024
Q2 | $74.4K | Buy |
243
+4
| +2% | +$1.23K | ﹤0.01% | 915 |
|
|
2024
Q1 | $85.4K | Sell |
239
-10
| -4% | -$3.58K | 0.01% | 768 |
|
|
2023
Q4 | $87.7K | Sell |
249
-5
| -2% | -$1.76K | 0.01% | 687 |
|
|
2023
Q3 | $95.3K | Buy |
254
+2
| +0.8% | +$750 | 0.01% | 579 |
|
|
2023
Q2 | $96.4K | Buy |
252
+7
| +3% | +$2.68K | 0.01% | 592 |
|
|
2023
Q1 | $84.9K | Buy |
245
+40
| +20% | +$13.9K | 0.01% | 596 |
|
|
2022
Q4 | $48.2K | Buy |
205
+147
| +253% | +$34.6K | 0.01% | 776 |
|
|
2022
Q3 | $14K | Sell |
58
-194
| -77% | -$46.8K | ﹤0.01% | 1031 |
|
|
2022
Q2 | $76K | Buy |
252
+115
| +84% | +$34.7K | 0.02% | 463 |
|
|
2022
Q1 | $56K | Sell |
137
-6
| -4% | -$2.45K | 0.01% | 450 |
|
|
2021
Q4 | $67K | Buy |
+143
| New | +$67K | 0.02% | 370 |
|